BR0016954A - Compostos derivados inovadores de heteroarila, composição farmacêutica, sua utilização e método de tratamento - Google Patents

Compostos derivados inovadores de heteroarila, composição farmacêutica, sua utilização e método de tratamento

Info

Publication number
BR0016954A
BR0016954A BR0016954-4A BR0016954A BR0016954A BR 0016954 A BR0016954 A BR 0016954A BR 0016954 A BR0016954 A BR 0016954A BR 0016954 A BR0016954 A BR 0016954A
Authority
BR
Brazil
Prior art keywords
innovative
pharmaceutical composition
treatment
derivative compounds
heteroaryl derivative
Prior art date
Application number
BR0016954-4A
Other languages
English (en)
Inventor
Thomas Ruhland
Ejner Knud Moltzen
Ivan Mikkelsen
Christian Krog-Jensen
Kim Andersen
Mario Rottlander
Gitte Mikkelsen
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of BR0016954A publication Critical patent/BR0016954A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)

Abstract

"COMPOSTOS DERIVADOS INOVADORES DE HETEROARILA, COMPOSIçãO FARMACêUTICA, SUA UTILIZAçãO E MéTODO DE TRATAMENTO". Derivado de heteroarila possuindo a fórmula (l), qualquer um de seus enantiómeros ou qualquer mistura dos mesmos, ou um sal com adição de ácido dos mesmos, onde X é -O-, -S- ou -CR^ 4^R^ 5^-; e Y é -CR^ 6^R^ 7^, -CR^ 6^R^ 7^ -CR^ 8^R^ 9^- ou CR^ 6^=CR^ 7^; ou X e Y formam juntos um grupo CR^ 4^=CR^ 5^-, ou CR^ 4^=CR^ 5^-CR^ 6^ R^ 7^-; Z é -O-, ou -S-; W é N, C ou CH; n é 2, 3,4,5,6,7,8,9 ou 10; m é 2 ou 3; A é O ou S onde as linhas pontilhadas significam uma união opcional. Os compostos da invenção são considerados úteis para o tratamento de distúrbios afetivos, tais como distúrbio de ansiedade geral, distúrbio de pânico, distúrbio compulsivo obsessivo, depressão, fobia social e distúrbios alimentares, e distúrbios neurológicos, tais como psicose.
BR0016954-4A 1999-12-30 2000-12-29 Compostos derivados inovadores de heteroarila, composição farmacêutica, sua utilização e método de tratamento BR0016954A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199901884 1999-12-30
PCT/DK2000/000741 WO2001049683A1 (en) 1999-12-30 2000-12-29 Novel heteroaryl derivatives, their preparation and use

Publications (1)

Publication Number Publication Date
BR0016954A true BR0016954A (pt) 2003-04-29

Family

ID=8108797

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0016954-4A BR0016954A (pt) 1999-12-30 2000-12-29 Compostos derivados inovadores de heteroarila, composição farmacêutica, sua utilização e método de tratamento

Country Status (22)

Country Link
US (1) US20030050306A1 (pt)
EP (1) EP1246820A1 (pt)
JP (1) JP2003519229A (pt)
KR (1) KR20020063286A (pt)
CN (1) CN1414963A (pt)
AR (1) AR027133A1 (pt)
AU (1) AU2352001A (pt)
BG (1) BG106846A (pt)
BR (1) BR0016954A (pt)
CA (1) CA2395984A1 (pt)
CZ (1) CZ20022280A3 (pt)
EA (1) EA200200733A1 (pt)
HU (1) HUP0204084A3 (pt)
IL (1) IL149993A0 (pt)
IS (1) IS6403A (pt)
NO (1) NO20023188D0 (pt)
NZ (1) NZ519478A (pt)
PL (1) PL355610A1 (pt)
SK (1) SK9432002A3 (pt)
TR (1) TR200201679T2 (pt)
WO (1) WO2001049683A1 (pt)
ZA (1) ZA200204464B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2323451T7 (es) 2001-07-20 2011-08-01 Psychogenics Inc. Tratamiento para el trastorno de hiperactividad con deficit de atencion.
TWI320783B (en) 2005-04-14 2010-02-21 Otsuka Pharma Co Ltd Heterocyclic compound
TWI329641B (en) * 2005-08-31 2010-09-01 Otsuka Pharma Co Ltd (benzo[b]thiophen-4-yl)piperazine compounds, pharmaceutical compositions comprising the same, uses of the same and processes for preparing the same
BRPI0714629A2 (pt) 2006-08-21 2013-05-07 Genentech Inc composto, composiÇço farmacÊutica, mÉtodo para inibir o crescimento celular, mÉtodo para tratar uma doenÇa inflamatària e mÉtodo para trataruma doenÇa auto-imune, lesço àsseo destrutiva, distérbios proliferativos, doenÇas infecciosas, doenÇas virais, doenÇas fibràticas ou doenÇas neurodegenerativas
JP4785881B2 (ja) * 2007-02-27 2011-10-05 大塚製薬株式会社 医薬

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK148392D0 (da) * 1992-12-09 1992-12-09 Lundbeck & Co As H Heterocykliske forbindelser
IT1266582B1 (it) * 1993-07-30 1997-01-09 Recordati Chem Pharm Derivati (di)azacicloesanici e diazacicloeptanici
AR022303A1 (es) * 1999-01-22 2002-09-04 Lundbeck & Co As H Derivados de piperidina, tetrahidropiridina y piperazina, su preparacion y utilizacion

Also Published As

Publication number Publication date
BG106846A (en) 2003-02-28
SK9432002A3 (en) 2002-11-06
EP1246820A1 (en) 2002-10-09
CN1414963A (zh) 2003-04-30
WO2001049683A1 (en) 2001-07-12
KR20020063286A (ko) 2002-08-01
AU2352001A (en) 2001-07-16
HUP0204084A3 (en) 2005-02-28
JP2003519229A (ja) 2003-06-17
CZ20022280A3 (cs) 2002-10-16
TR200201679T2 (tr) 2002-10-21
IL149993A0 (en) 2002-12-01
HUP0204084A2 (hu) 2003-03-28
PL355610A1 (en) 2004-05-04
CA2395984A1 (en) 2001-07-12
NO20023188L (no) 2002-07-01
EA200200733A1 (ru) 2002-12-26
AR027133A1 (es) 2003-03-12
NO20023188D0 (no) 2002-07-01
IS6403A (is) 2002-05-31
ZA200204464B (en) 2003-09-04
NZ519478A (en) 2004-02-27
US20030050306A1 (en) 2003-03-13

Similar Documents

Publication Publication Date Title
BR0009007A (pt) Derivados de piperidina, tetraidropiridina epiperazina; composto; composição farmacêutica;utilização e método
DE69921804D1 (de) Benzamid-derivate zur behandlung cytokin-vermittelter krankheiten
DE60220422D1 (de) Substituierte pyrazoloverbindungen zur behandlung von entzündungen
ATE411280T1 (de) Phenoxyessigsäure-derivate zur behandlung von störungen der atemwege
BRPI0411275A (pt) compostos de carbonila como inibidores de histona deacetilase para tratamento de doenças; composição farmacêutica; método de modular a atividade catalìtica de hdac; método de tratar doença em um indivìduo; utilização de um composto ou composição; método de inibir hdac
BR9807339A (pt) Derivados 3-piperidil-4-oxoquinazolina e composições farmacêuticas compreendendo os mesmos.
BR9708815A (pt) Composições farmacêuticas para prevenção e tratamento de desordens do sistema nervoso central.
NZ338016A (en) Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same
BR9508308A (pt) Derivados de benzoíla e sintese dos mesmos
ATE181235T1 (de) Pharmazeutische zusammensetzungen und verfahren unter verwendung von isobutyramid zur behandlung von betaglobinerkrankungen
RU94023250A (ru) 2,3-дигидро-1,4-бензодиоксин-5-ил-пиперазиновые производные, обладающие 5-нт1а-антагонистической активностью, способы их получения, фармкомпозиция на их основе, получение ее и способ лечения расстройств нервной системы
DE69807587T2 (de) Quinazolin-4-on AMPA Antagonisten
DE69837564D1 (de) Azaheterozyklischederivate zur behandlung von haarausfall und neurologischer krankheiten
ATE334120T1 (de) Pharmazeutische zusammensetzungen zur vorbeugung und behandlung von störungen des zentralnervensystems
BR0016954A (pt) Compostos derivados inovadores de heteroarila, composição farmacêutica, sua utilização e método de tratamento
DE3681690D1 (de) N-substituierte 3-piperidin- oder 3-pyridincarbonsaeuren und deren derivate.
BR0210401A (pt) Composto, composição farmacêutica, uso de um composto e método para o tratamento de um distúrbio ou de uma doença de um corpo de animal vivo, incluindo um humano
DE60018704D1 (de) Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen
FR2763335B1 (fr) Nouveaux composes heterocycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DE60104986D1 (de) Xanthinderivate, zwischenprodukte und verwendung zur behandlung von osteoporosis
ATE263769T1 (de) Indolmorphinan-derivate und medikamente zur behandlung/mittel zur vorbeugung von cerebralen störungen
BRPI0410613A (pt) preparação de quinoxalinas substituìdas a partir da dianlina com 2,3-diidróxi-1,4-dioxano
ATE409469T1 (de) Verwendung von 2,2,3,3, tetramethylcyclopropane carbonsäure derivaten zur behandlung von psychiatrischen störungen
BR0210407A (pt) Composto, composição farmacêutica, uso de um composto e método de tratamento de um distúrbio ou de uma doença de corpo animal vivo, incluindo um humano
BR0205220A (pt) Derivados de fenilpiperazina, método para a preparação de um composto, composição farmacêutica, e, métodos de tratamento do mal de parkinson, e de distúrbios de cns tais como esquizofrenia, ansiedade e depressão

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1929 DE 26/12/2007.